Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick J Eulitt

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Current Opinion in Urology|March 12, 2019
Perioperative systemic therapy for bladder cancerPatrick J Eulitt, Marc A Bjurlin, Matthew I Milowsky
CNS Oncology|November 29, 2019
Hemophagocytic lymphohistiocytosis in a patient with glioblastoma: a case reportVaibhav Kumar, Patrick J Eulitt, Ana Bermudez, et al.
Cancer Biology & Therapy|October 16, 2010
Enhancing mda-7/IL-24 therapy in renal carcinoma cells by inhibiting multiple protective signaling pathways using sorafenib and by Ad.5/3 gene deliveryPatrick J Eulitt, Margaret A Park, Hamed Hossein, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 30, 2024
Retraction Notice to: Inhibition of Multiple Protective Signaling Pathways and Ad.5/3 Delivery Enhances mda-7/IL-24 Therapy of Malignant GliomaHossein A Hamed, Adly Yacoub, Margaret A Park, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 25, 2010
Inhibition of multiple protective signaling pathways and Ad.5/3 delivery enhances mda-7/IL-24 therapy of malignant gliomaHossein A Hamed, Adly Yacoub, Margaret A Park, et al.
Clinical Genitourinary Cancer|March 10, 2020
Pilot Study of [<sup>18</sup>F] Fluorodeoxyglucose Positron Emission Tomography (FDG-PET)/Magnetic Resonance Imaging (MRI) for Staging of Muscle-invasive Bladder Cancer (MIBC)Patrick J Eulitt, Ersan Altun, Arif Sheikh, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Current Opinion in Urology|March 12, 2019
Perioperative systemic therapy for bladder cancerPatrick J Eulitt, Marc A Bjurlin, Matthew I Milowsky
CNS Oncology|November 29, 2019
Hemophagocytic lymphohistiocytosis in a patient with glioblastoma: a case reportVaibhav Kumar, Patrick J Eulitt, Ana Bermudez, et al.
Cancer Biology & Therapy|October 16, 2010
Enhancing mda-7/IL-24 therapy in renal carcinoma cells by inhibiting multiple protective signaling pathways using sorafenib and by Ad.5/3 gene deliveryPatrick J Eulitt, Margaret A Park, Hamed Hossein, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 30, 2024
Retraction Notice to: Inhibition of Multiple Protective Signaling Pathways and Ad.5/3 Delivery Enhances mda-7/IL-24 Therapy of Malignant GliomaHossein A Hamed, Adly Yacoub, Margaret A Park, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 25, 2010
Inhibition of multiple protective signaling pathways and Ad.5/3 delivery enhances mda-7/IL-24 therapy of malignant gliomaHossein A Hamed, Adly Yacoub, Margaret A Park, et al.
Clinical Genitourinary Cancer|March 10, 2020
Pilot Study of [<sup>18</sup>F] Fluorodeoxyglucose Positron Emission Tomography (FDG-PET)/Magnetic Resonance Imaging (MRI) for Staging of Muscle-invasive Bladder Cancer (MIBC)Patrick J Eulitt, Ersan Altun, Arif Sheikh, et al.
Pageof 1